Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Industry First -- Supermicro Systems Certified by Intel for an Immersion Cooling Solution
-
Olin and K2 Announce Strategic Expansion of Bleach Distribution Partnership in California and the Western United States
-
Ameresco to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
FrontView REIT Appoints Pierre Revol, Seasoned Industry Executive, as Chief Financial Officer
-
RGP Announces Board Refreshment
-
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist
-
BGC Group Updates its Outlook for the Second Quarter of 2025
-
LogProstyle Inc. Announces Results of the 2025 Annual General Meeting of Shareholders
-
SkyWater Completes Acquisition of Fab 25, Expanding U.S. Pure-Play Foundry Capacity for Critical Semiconductor Technologies
-
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
-
Agree Realty Announces Second Quarter 2025 Earnings Release Date and Conference Call Information
-
Lumen Technologies Advances Financial Strategy to Support AI-Era Infrastructure Growth
-
Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025
-
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
-
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
-
Yorkville Acquisition Corp. Announces Closing of $172,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
-
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology
-
Zeo Energy Corp. Joins Russell Microcap® Index
-
Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
-
Results of Operations for the Three Months Ended March 31, 2025 - American Overseas Group Limited Announces Net Income Of $4.3 Million For the Three Months Ended March 31, 2025.
-
Ascent Industries Co. Completes Sale of American Stainless Tubing, Finalizing Transformation to Pure-Play Specialty Chemicals Platform
-
Enphase Energy Board of Directors Affirms Re-election of Thurman John Rodgers as Director of the Board
-
Top California Lender Welcomes New Investors to Fuel Expanded Lending Capacity
-
Nektar Therapeutics Announces Proposed Public Offering
-
Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade S
-
SATO Technologies Corp. Provides Results From Shareholder Meeting
-
SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BRMK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Broadmark Realty Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
DMRC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BITF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitfarms Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Timothy Plan Announces Liquidation of Timothy Plan Market Neutral ETF (TPMN)
-
I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research
-
Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome
-
Hudson Pacific Provides Business Update
-
Prestige Global Meeting Source Announces Strategic Leadership Additions with Appointment of First-Ever President and Welcomes New Executive Vice President of Sales
-
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
-
Bank OZK Announces Date for Second Quarter 2025 Earnings Release and Conference Call
-
VersaClimber's Virtual Fitness Challenge Engages 3,000+ in Everest Ascent from Home
-
The Herzfeld Caribbean Basin Fund, Inc. Pays Distribution
-
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
-
L.B. Foster Company Completes Successful Amendment to its Revolving Credit Agreement
-
HCA Healthcare, Inc. 2nd Quarter 2025 Earnings Conference Call
-
GONDI Debuts Full-Stack NFT Liquidity Marketplace & Now Supports ERC-20 Loans
